Cocaine trafficking reaching record highs, says EU drug agency

By |junij 6th, 2019|Berlin, cannabis, cocaine, dependence, Drug emergency centre, drugs, EMCCDA, Germany, MDMA, mental health, News, Turkey|

Cocaine seizure in the EU reached record highs in 2017 and the trafficking of synthetic drugs has also increased, according to this year's European Drug Report. A closer look into Berlin's drug help centre shows how drug consumption is linked to mental health. EURACTIV Germany reports.

Komentarji so izklopljeni za Cocaine trafficking reaching record highs, says EU drug agency

Heavy workload delays EU report on environmental impact of drugs

By |junij 19th, 2018|Antimicrobial resistance, drugs, medicines, News|

The European Commission’s much-awaited communication on the environmental impact of pharmaceuticals is at an “advanced stage” but might not be adopted in the near future because of other legislative initiatives on the agenda, an EU official has told EURACTIV.com.

Komentarji so izklopljeni za Heavy workload delays EU report on environmental impact of drugs

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

By |junij 12th, 2018|drugs, generic drugs, generic medicine, generics, News, SPC manufacturing waiver|

The European Commission’s proposal to add an SPC manufacturing waiver on exports will not damage innovation, as the pharma industry claims, and only intends to support small and medium generic drug companies, according to EU Health Commissioner Vytenis Andriukaitis.

Komentarji so izklopljeni za Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

Philippines bars EU party official critical of Duterte

By |april 16th, 2018|authoritarian regime, drugs, European Parliament, News, PES, Philippines, Sergei Stanishev|

The Philippines has barred entry to an EU party official critical of President Rodrigo Duterte's brutal drugs crackdown, in a move denounced by critics Monday (16 April) as a gag on dissent.

Komentarji so izklopljeni za Philippines bars EU party official critical of Duterte

Bitcoin and darknet, European dealers’ toolkit

By |december 5th, 2017|Bitcoin, darknet, drugs, europol, News|

The dismantling of online drug platforms last summer has highlighted the primary role of e-commerce for Europe’s drug trade. EURACTIV France reports.

Komentarji so izklopljeni za Bitcoin and darknet, European dealers’ toolkit

Athens brings its dispute with pharma industry to the EU Council

By |november 24th, 2017|drug pricing, drug trade, drugs, medicines, News|

The next EU Health Council on 8 December will discuss the “lack of drug availability in Greece”, amid mounting tensions between the leftist government in Athens and the pharmaceutical companies.

Komentarji so izklopljeni za Athens brings its dispute with pharma industry to the EU Council

EMA relocation should consider the wellbeing of all Europeans

By |november 10th, 2017|Brexit, drugs, EMA, EMA relocation, EU agencies, Health, Milan, News|

The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in orde...

Komentarji so izklopljeni za EMA relocation should consider the wellbeing of all Europeans

Pharmaceutical company gives free access to drug after clash with Greek government

By |november 2nd, 2017|drug pricing, drugs, medicines, News|

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients for free.

Komentarji so izklopljeni za Pharmaceutical company gives free access to drug after clash with Greek government

New Commission study fuels generic drugs industry ‘manufacturing dispute’

By |oktober 13th, 2017|Biosimilar medicines, drugs, EFPIA, generic drugs, generics, intellectual property rights, medicines for europe, News, patent, pharmaceutical companies, pharmaceuticals|

The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.

Komentarji so izklopljeni za New Commission study fuels generic drugs industry ‘manufacturing dispute’

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

By |oktober 12th, 2017|drugs, generic drugs, News, Orphan drugs, pharmaceuticals, rare diseases|

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.

Komentarji so izklopljeni za Patients: ‘Think carefully’ before questioning orphan drugs’ incentives